| DC Field | Value | Language |
|---|
| dc.contributor.author | Turcan, Valeria | - |
| dc.date.accessioned | 2020-07-06T11:11:05Z | - |
| dc.date.available | 2020-07-06T11:11:05Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | Valeria TURCAN. Evaluation of the thromboembolic risk in patients with atrial fibrillation. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 48-49. | en_US |
| dc.identifier.uri | https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf | - |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/10999 | - |
| dc.description | Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova | en_US |
| dc.description.abstract | Introduction. Atrial fibrillation (AF) is considered to be a new 21st-century epidemic, which by
the end of 2060 shall affect an estimated 18 million people. More than 6 million Europeans
suffer from AF, while in the United States AF is the cause of hospitalization of more than one
third of the patients with heart rhythm disorders. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | MedEspera | en_US |
| dc.subject | atrial fibrillation | en_US |
| dc.subject | stroke | en_US |
| dc.subject | thromboembolism | en_US |
| dc.title | Evaluation of the thromboembolic risk in patients with atrial fibrillation | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | MedEspera 2018
|
